MERTK inhibition selectively activates a DC - T-cell axis to provide anti-leukemia immunity. Huelse JM, Bhasin SS, Jacobsen KM, Yim J, et al. Leukemia 2024 Sep 25. doi: 10.1038/s41375-024-02408.

Read + Share

Amedeo Smart

Independent Medical Education

Huelse JM, Bhasin SS, Jacobsen KM, Yim J, et al. MERTK inhibition selectively activates a DC - T-cell axis to provide anti-leukemia immunity. Leukemia 2024 Sep 25. doi: 10.1038/s41375-024-02408.
PMID: 39322710